{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:33:33Z","timestamp":1792816413101,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jaci.2016.12.992","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T10:46:02Z","timestamp":1491561962000},"page":"1643-1650.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation"],"prefix":"10.1016","volume":"140","author":[{"given":"Rick","family":"Admiraal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coco C.H.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Lindemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc B.","family":"Bierings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie M.J.","family":"Wensing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Birgitta","family":"Versluys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom F.W.","family":"Wolfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Nierkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap Jan","family":"Boelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2016.12.992_bib1","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/bmt.2010.306","article-title":"Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT","volume":"46","author":"B\u00fclmann","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaci.2016.12.992_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbmt.2012.10.010","article-title":"Immune reconstitution kinetics as an early predictor for mortality using various hematopoietic stem cell sources in children","volume":"19","author":"Bartelink","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaci.2016.12.992_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.bmt.1705870","article-title":"Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality","volume":"41","author":"Berger","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaci.2016.12.992_bib4","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1111\/ajt.13241","article-title":"Donor CD4 T cell diversity determines virus reactivation in patients after HLA-matched allogeneic stem cell transplantation","volume":"15","author":"Ritter","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jaci.2016.12.992_bib5","first-page":"174","article-title":"The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation","volume":"10","author":"Fedele","year":"2012","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jaci.2016.12.992_bib6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/sj.bmt.1705381","article-title":"Rapid helper T-cell recovery above 200 \u00d7 106\/L at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation","volume":"37","author":"Kim","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaci.2016.12.992_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/bmt.2008.403","article-title":"Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT","volume":"43","author":"Pourgheysari","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaci.2016.12.992_bib8","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V95.7.2240","article-title":"Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation","volume":"95","author":"Broers","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.12.992_bib9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2141.2011.08994.x","article-title":"Omission of in\u00a0vivo T-cell depletion promotes rapid expansion of naive CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant","volume":"156","author":"Chiesa","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2016.12.992_bib10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/bmt.2012.221","article-title":"Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients","volume":"48","author":"Hiwarkar","year":"2013","journal-title":"Bone Marrow Translant"},{"key":"10.1016\/j.jaci.2016.12.992_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.jaci.2016.12.992_bib12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A\u00a0long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2016.12.992_bib13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ccm.2005.06.009","article-title":"Acute lung injury after hematopoietic stem cell transplantation","volume":"26","author":"Peters","year":"2005","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jaci.2016.12.992_bib14","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2352-3026(15)00045-9","article-title":"Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jaci.2016.12.992_bib15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","article-title":"Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity","volume":"101","author":"Boeckh","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.12.992_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbmt.2014.01.001","article-title":"Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation","volume":"20","author":"Servais","year":"2014","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.jaci.2016.12.992_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1083-8791(03)00102-2","article-title":"Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival","volume":"9","author":"Bruno","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaci.2016.12.992_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/ejh.12260","article-title":"Controlled Epstein-Barr virus reactivation after allogeneic transplantation is associated with improved survival","volume":"92","author":"Auger","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaci.2016.12.992_bib19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/tid.12229","article-title":"Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease","volume":"16","author":"Gotoh","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jaci.2016.12.992_bib20","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/bmt.2013.78","article-title":"Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT","volume":"48","author":"de Pagter","year":"2013","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jaci.2016.12.992_bib21","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1086\/428060","article-title":"Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation","volume":"40","author":"Zerr","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2016.12.992_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/petr.12572","article-title":"Human herpesvirus-6 viremia is not associated with poor clinical outcomes in children following allogeneic hematopoietic cell transplantation","volume":"19","author":"Violago","year":"2015","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jaci.2016.12.992_bib23","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/j.transproceed.2010.07.027","article-title":"Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation","volume":"42","author":"Jaskula","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaci.2016.12.992_bib24","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia","volume":"122","author":"Green","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.12.992_bib25","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1182\/blood-2013-05-499830","article-title":"CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT","volume":"122","author":"Schmidt-Hieber","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.12.992_bib26","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis","volume":"127","author":"Teira","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.12.992_bib27","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/bmt.2013.235","article-title":"High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"49","author":"Gilis","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaci.2016.12.992_bib28","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1182\/blood-2016-06-721936","article-title":"Excellent T-cell reconstitution and survival provided ATG exposure is low or absent after pediatric cord blood transplantation","volume":"128","author":"Admiraal","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.12.992_bib29","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1182\/blood-2016-06-724005","article-title":"Strategies before, during, and after hematopoietic cell transplantation to improve T-cell immune-reconstitution","volume":"128","author":"de Koning","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.12.992_bib30","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1084\/jem.20131289","article-title":"Sex steroid blockade enhances thymopoiesis by modulating Notch signaling","volume":"211","author":"Velardi","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2016.12.992_bib31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.exphem.2003.10.016","article-title":"Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions","volume":"32","author":"Nadal","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jaci.2016.12.992_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.seminhematol.2007.04.009","article-title":"Hematopoietic growth factors including keratinocyte growth factor in allogeneic and autologous stem cell transplantation","volume":"44","author":"Seggewiss","year":"2007","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jaci.2016.12.992_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.2010.05486.x","article-title":"Thymosin alpha1 to harness immunity to pathogens after haploidentical hematopoietic transplantation","volume":"1194","author":"Perruccio","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaci.2016.12.992_bib34","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.jcyt.2015.09.008","article-title":"Challenges in the harmonization of immune monitoring studies and trial design for cell-based therapies in the context of hematopoietic cell transplantation for pediatric cancer patients","volume":"17","author":"Nierkens","year":"2015","journal-title":"Cytotherapy"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674917305717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674917305717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:08:08Z","timestamp":1758791288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674917305717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0091674917305717"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2016.12.992","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727493897.793540523","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2016.12.992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}